NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 128 filers reported holding NEVRO CORP in Q4 2015. The put-call ratio across all filers is 1.89 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $272,578 | -22.9% | 14,182 | +1.9% | 0.00% | – |
| Q2 2023 | $353,719 | -26.5% | 13,915 | +4.5% | 0.00% | -100.0% |
| Q1 2023 | $481,446 | -8.7% | 13,318 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $527,393 | -15.0% | 13,318 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $620,619 | +6.3% | 13,318 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $584,000 | -40.8% | 13,318 | -2.3% | 0.00% | -50.0% |
| Q1 2022 | $986,000 | -9.5% | 13,635 | +1.5% | 0.00% | 0.0% |
| Q4 2021 | $1,089,000 | -31.0% | 13,437 | -0.9% | 0.00% | -33.3% |
| Q3 2021 | $1,578,000 | -97.7% | 13,558 | -96.7% | 0.00% | -97.7% |
| Q2 2021 | $68,925,000 | +10.3% | 415,740 | -7.2% | 0.13% | +5.6% |
| Q1 2021 | $62,469,000 | +2.0% | 447,807 | +26.5% | 0.13% | +1.6% |
| Q4 2020 | $61,260,000 | +16.9% | 353,899 | -5.9% | 0.12% | +6.9% |
| Q3 2020 | $52,400,000 | +10.7% | 376,168 | -5.0% | 0.12% | +5.5% |
| Q2 2020 | $47,321,000 | +186.7% | 396,093 | +139.9% | 0.11% | +150.0% |
| Q1 2020 | $16,507,000 | +841.6% | 165,100 | +1007.1% | 0.04% | +1000.0% |
| Q4 2019 | $1,753,000 | +73.2% | 14,913 | +26.7% | 0.00% | +100.0% |
| Q3 2019 | $1,012,000 | +32.6% | 11,766 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $763,000 | +2.1% | 11,766 | -1.5% | 0.00% | 0.0% |
| Q1 2019 | $747,000 | +58.3% | 11,947 | -1.7% | 0.00% | +100.0% |
| Q4 2018 | $472,000 | -28.6% | 12,149 | +4.7% | 0.00% | 0.0% |
| Q3 2018 | $661,000 | -28.6% | 11,603 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $926,000 | -13.1% | 11,603 | -5.6% | 0.00% | 0.0% |
| Q1 2018 | $1,066,000 | +23.7% | 12,297 | -1.5% | 0.00% | 0.0% |
| Q4 2017 | $862,000 | -25.8% | 12,488 | -2.3% | 0.00% | 0.0% |
| Q3 2017 | $1,162,000 | +22.1% | 12,787 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $952,000 | -97.8% | 12,787 | -97.3% | 0.00% | -98.0% |
| Q1 2017 | $44,228,000 | +34.1% | 472,017 | +4.0% | 0.10% | +27.8% |
| Q4 2016 | $32,983,000 | -17.1% | 453,947 | +19.1% | 0.08% | +5.3% |
| Q3 2016 | $39,775,000 | +100.8% | 381,020 | +41.8% | 0.08% | +53.1% |
| Q2 2016 | $19,813,000 | +5328.2% | 268,615 | +4037.0% | 0.05% | +4800.0% |
| Q1 2016 | $365,000 | -16.7% | 6,493 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $438,000 | +45.5% | 6,493 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $301,000 | -13.8% | 6,493 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $349,000 | – | 6,493 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,446,333 | $82,441,000 | 4.44% |
| Asymmetry Capital Management, L.P. | 31,379 | $1,789,000 | 1.65% |
| TIRSCHWELL & LOEWY INC | 194,470 | $11,085,000 | 1.38% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 673,480 | $38,388,000 | 1.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 525,040 | $29,927,000 | 1.07% |
| Orbimed Advisors | 1,357,691 | $77,388,000 | 0.93% |
| Sio Capital Management, LLC | 45,091 | $2,570,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 60,000 | $3,420,000 | 0.72% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 159,800 | $9,109,000 | 0.62% |
| Endurant Capital Management LP | 24,171 | $1,378,000 | 0.61% |